美好医疗 (301363.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

26.2x

Market Cap

CNY 12.86B

MomentumView details →

1D Return

−4.21%

YTD Return

−33.35%

RSI (14)

42.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

26.2x

Market Cap

CNY 12.86B

RSI (14)

42.1

MomentumView details →

1D Return

−4.21%

YTD Return

−33.35%

ProfitabilityView details →

Gross Margin

40.51%

Net Margin

16.61%

EBITDA Margin

24.95%

ROE (TTM)

7.61%

ROA (TTM)

6.77%

Asset Turnover

0.41x

GrowthView details →

Revenue YoY

+7.73%

EPS YoY

−19.08%

FCF YoY

—

Revenue CAGR 3Y

+4.72%

EPS CAGR 3Y

−22.64%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

6.27x

Quick Ratio

5.26x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.73B

Net Income (TTM)

287.89M

Op. CF (TTM)

421.44M

Latest newsMore news →

Mehow Medical announced in a recent conference call that its MT ferrule product is still in the sample research and development stage, with first samples expected by the end of Q3 2026.17d ago

Meihao Medical reported H1 2026 results: revenue of 813 million yuan, up 10.97% year-on-year; net profit attributable to shareholders of 124 million yuan, up 8.77%; gross margin of 40.88%, up 3.36 percentage points; operating cash flow of 166 million yuan, up 48.27%.17d ago

Similar companies

诺瓦星云301589.SZ 共达电声002655.SZ 涪陵榨菜002507.SZ 东方锆业002167.SZ 伟星股份002003.SZ 翔鹭钨业002842.SZ

Latest newsMore news →

Mehow Medical announced in a recent conference call that its MT ferrule product is still in the sample research and development stage, with first samples expected by the end of Q3 2026.17d ago Meihao Medical reported H1 2026 results: revenue of 813 million yuan, up 10.97% year-on-year; net profit attributable to shareholders of 124 million yuan, up 8.77%; gross margin of 40.88%, up 3.36 percentage points; operating cash flow of 166 million yuan, up 48.27%.17d ago